FAT1: a potential target for monoclonal antibody therapy in colon cancer

BACKGROUND: Colorectal cancer (CRC) is one of the major causes of cancer-associated mortality worldwide. The currently approved therapeutic agents have limited efficacy. METHODS: The atypical cadherin FAT1 was discovered as a novel CRC-associated protein by using a monoclonal antibody (mAb198.3). FA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pileri, Piero, Campagnoli, Susanna, Grandi, Alberto, Parri, Matteo, De Camilli, Elisa, Song, Chaojun, Ganfini, Luisa, Lacombe, Aurelien, Naldi, Ilaria, Sarmientos, Paolo, Cinti, Caterina, Jin, Boquan, Grandi, Guido, Viale, Giuseppe, Terracciano, Luigi, Grifantini, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931367/
https://www.ncbi.nlm.nih.gov/pubmed/27328312
http://dx.doi.org/10.1038/bjc.2016.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931367/
https://www.ncbi.nlm.nih.gov/pubmed/27328312
http://dx.doi.org/10.1038/bjc.2016.145

Ejemplares similares